122 related articles for article (PubMed ID: 2627989)
1. Autologous bone marrow transplantation with immunotoxin-purged marrow for advanced multiple myeloma.
Gobbi M; Cavo M; Tazzari PL; Dinota A; Tassi C; Bontadini A; Albertazzi L; Miggiano C; Rizzi S; Rosti G
Eur J Haematol Suppl; 1989; 51():176-81. PubMed ID: 2627989
[TBL] [Abstract][Full Text] [Related]
2. Autologous bone marrow transplantation with immunotoxin purged marrow for multiple myeloma. Long term results in 14 patients with advanced disease.
Gobbi M; Tazzari PL; Cavo M; Tassi C; Grimaldi M; Meloni G; Di Nucci G; Vignetti M; Bolognesi A; Stirpe F
Bone Marrow Transplant; 1991; 7 Suppl 2():30. PubMed ID: 1878704
[No Abstract] [Full Text] [Related]
3. Monoclonal antibody-purged autologous bone marrow transplantation therapy for multiple myeloma.
Anderson KC; Barut BA; Ritz J; Freedman AS; Takvorian T; Rabinowe SN; Soiffer R; Heflin L; Coral F; Dear K
Blood; 1991 Feb; 77(4):712-20. PubMed ID: 1993214
[TBL] [Abstract][Full Text] [Related]
4. An immunotoxin containing momordin suitable for bone marrow purging in multiple myeloma patients.
Dinota A; Barbieri L; Gobbi M; Tazzari PL; Rizzi S; Bontadini A; Bolognesi A; Tura S; Stirpe F
Br J Cancer; 1989 Sep; 60(3):315-9. PubMed ID: 2789938
[TBL] [Abstract][Full Text] [Related]
5. Autologous transplantation of an immunomagnetic bead purged marrow in patients with relapsed acute lymphoblastic leukemia.
Körbling M; Knauf W; Funderud S; Kvalheim G; Hunstein W
Haematologica; 1991 Mar; 76 Suppl 1():29-36. PubMed ID: 1650742
[TBL] [Abstract][Full Text] [Related]
6. Treatment of multiple myeloma with intensive chemotherapy followed by autologous BMT using marrow purged with 4-hydroperoxycyclophosphamide.
Reece DE; Barnett MJ; Connors JM; Klingemann HG; O'Reilly SE; Shepherd JD; Sutherland HJ; Phillips GL
Bone Marrow Transplant; 1993 Feb; 11(2):139-46. PubMed ID: 8435663
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and toxicity of plasma-cell-reactive monoclonal antibodies B-B2 and B-B4 and their immunotoxins.
Vooijs WC; Post J; Wijdenes J; Schuurman HJ; Bolognesi A; Polito L; Stirpe F; Bast EJ; de Gast GC
Cancer Immunol Immunother; 1996 Jul; 42(6):319-28. PubMed ID: 8830734
[TBL] [Abstract][Full Text] [Related]
8. Immunomagnetic purging procedure for autologous bone marrow transplantation in lymphoid malignancies.
De Rosa L; Montuoro A; Pandolfi A; Lanti T; Pescador L; Morara R; De Laurenzi A
Haematologica; 1991 Mar; 76 Suppl 1():37-40. PubMed ID: 1864552
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo chemopurging of autologous bone marrow with 4-hydroperoxycyclophosphamide to eliminate occult leukemic cells. Laboratory and clinical observations.
Yeager AM; Rowley SD; Kaizer H; Santos GW
Am J Pediatr Hematol Oncol; 1990; 12(3):245-56. PubMed ID: 2240470
[TBL] [Abstract][Full Text] [Related]
10. Relapse of multiple myeloma in extramedullary sites after autologous bone marrow transplantation.
Sanfructuoso C; Caballero MD; Garcia-Sanz R; Vidriales B; Vazquez L; San Miguel JF
Eur J Haematol; 1996 Mar; 56(3):181-3. PubMed ID: 8598240
[No Abstract] [Full Text] [Related]
11. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
Lemoli RM; Cavo M; Fortuna A
J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
[TBL] [Abstract][Full Text] [Related]
12. Multiple myeloma in serologic complete remission after autologous stem cell transplantation: impact of bone marrow plasma cell assessment by conventional morphology on disease progression.
Fernández de Larrea C; Tovar N; Rozman M; Rosiñol L; Aróstegui JI; Cibeira MT; Rovira M; Yagüe J; Bladé J
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1084-7. PubMed ID: 21215814
[TBL] [Abstract][Full Text] [Related]
13. Elimination of clonogenic breast cancer cells from human bone marrow. A comparison of immunotoxin treatment with chemoimmunoseparation using 4-hydroperoxycyclophosphamide, monoclonal antibodies, and magnetic microspheres.
O'Briant KC; Shpall EJ; Houston LL; Peters WP; Bast RC
Cancer; 1991 Sep; 68(6):1272-8. PubMed ID: 1873781
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo bone marrow purging with immunotoxins.
Stirpe F; Barbieri L; Tazzari PL; Dinota A; Gobbi M
Eur J Haematol Suppl; 1989; 51():173-5. PubMed ID: 2627988
[No Abstract] [Full Text] [Related]
15. Autologous bone marrow transplantation therapy for multiple myeloma.
Anderson KC; Barut BA; Ritz J; Freedman AS; Nadler LM
Eur J Haematol Suppl; 1989; 51():157-63. PubMed ID: 2697588
[TBL] [Abstract][Full Text] [Related]
16. Autologous bone marrow transplant using 4-HC, VP-16 purged bone marrow for acute non-lymphoblastic leukemia.
Gulati SC; Shank B; Sarris A; Berman E; Gee T; Cunningham I; Flomenberg N; O'Reilly RJ; Clarkson B
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():116-8. PubMed ID: 2653485
[No Abstract] [Full Text] [Related]
17. High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.
Freedman AS; Neuberg D; Gribben JG; Mauch P; Soiffer RJ; Fisher DC; Anderson KC; Andersen N; Schlossman R; Kroon M; Ritz J; Aster J; Nadler LM
J Clin Oncol; 1998 Jan; 16(1):13-8. PubMed ID: 9440717
[TBL] [Abstract][Full Text] [Related]
18. Hemopoietic reconstitution after repeated autologous transplantation with mafosfamide-purged marrow.
Beaujean F; Hartmann O; Benhamou E; Lemerle J; Duedari N
Bone Marrow Transplant; 1989 Sep; 4(5):537-41. PubMed ID: 2790332
[TBL] [Abstract][Full Text] [Related]
19. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
[TBL] [Abstract][Full Text] [Related]
20. Comparison of myeloma cell contamination of bone marrow and peripheral blood stem cell harvests.
Henry JM; Sykes PJ; Brisco MJ; To LB; Juttner CA; Morley AA
Br J Haematol; 1996 Mar; 92(3):614-9. PubMed ID: 8616025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
